Exovate 0.05% contains Clobetasol Propionate, a super-high potency topical corticosteroid belonging to the therapeutic class of Other Topical Corticosteroids. It is formulated for the short-term management of severe inflammatory skin disorders that do not respond adequately to less potent topical steroids. Exovate 0.05% provides rapid relief from inflammation, itching, and redness, making it suitable for controlled use in adults, elderly patients, and children over 1 year of age under medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Clobetasol Propionate in Exovate 0.05% is indicated for the treatment of the following dermatoses:

• Psoriasis (excluding widespread plaque psoriasis)

• Recalcitrant dermatoses

• Lichen planus

• Discoid lupus erythematosus

• Other corticosteroid-responsive skin conditions that fail to respond to less potent topical steroids

Pharmacology

Clobetasol Propionate is a very potent topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. Its anti-inflammatory activity occurs through multiple mechanisms, including inhibition of late-phase allergic reactions. It reduces mast cell density, suppresses chemotaxis and activation of eosinophils, decreases cytokine production, and inhibits arachidonic acid metabolism, resulting in marked reduction of inflammation and itching.

Dosage

Cream and Ointment

• Adults, elderly, and children over 1 year:

  • Apply a thin layer to the affected area twice daily and rub in gently

  • Treatment duration should not exceed 2 consecutive weeks

  • Maximum dose: 50 g per week

  • In children, treatment should ideally be limited to 5 days and reviewed weekly

Scalp Solution

• Apply once or twice daily to affected scalp areas

• Total weekly dose should not exceed 50 ml

• Use for short durations only and discontinue if no response is seen within one week

Topical Spray

• Apply twice daily directly to affected skin and rub in gently

• Maximum weekly dose: 50 g (59 ml)

• Do not exceed 26 sprays per application or 52 sprays per day

• Treatment duration should not exceed 4 weeks

• Use in patients under 18 years is not recommended

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Administration

• Route of administration: Cutaneous use only

• Creams are suitable for moist or weeping lesions

• Ointments are preferred for dry, thickened, or scaly skin conditions

Drug Interactions

Drugs that inhibit CYP3A4 (such as ritonavir and itraconazole) may reduce the metabolism of corticosteroids, increasing systemic exposure and the risk of adverse effects.

Contraindications

Exovate 0.05% is contraindicated in patients with:

• Hypersensitivity to Clobetasol Propionate or any formulation component

• Rosacea

• Acne vulgaris

• Perioral dermatitis

• Perianal and genital pruritus

• Pruritus without inflammation

• Untreated cutaneous infections

Side Effects

Commonly reported side effects include:

• Burning sensation

• Stinging

Less frequent adverse effects include itching, skin atrophy, cracking, and fissuring. Prolonged or excessive use may lead to systemic absorption and rare cases of Cushing’s syndrome, especially in infants and adults.

Pregnancy and Lactation

There are limited data on the use of Clobetasol Propionate during pregnancy. Animal studies have shown potential fetal abnormalities with topical corticosteroids, though relevance to humans is unclear. Exovate 0.05% should be used during pregnancy and lactation only if the expected benefit outweighs potential risks. Caution is advised in nursing mothers as excretion in human milk is unknown.

Precautions and Warnings

• Clean skin before applying a fresh occlusive dressing

• Use with caution in psoriasis due to risk of rebound relapse

• Facial use should be limited to 5 days

• Avoid contact with eyes; prolonged eyelid use may cause cataract or glaucoma

• Long-term continuous use, especially in children, should be avoided

Overdose Effects

Acute overdose is unlikely. Chronic overuse or misuse may result in symptoms of hypercortisolism. In such cases, gradual discontinuation of the topical steroid is recommended.

Storage Conditions

Store below 30°C, protected from light and moisture. Do not freeze. Keep out of the reach of children.

Use in Special Populations

In infants and children under 12 years, prolonged continuous use should be avoided due to the risk of adrenal suppression and skin atrophy.